title: Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis.
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Chiara
authors.initials: C
authors.lastname: Giacomassi
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Norzawani
authors.initials: N
authors.lastname: Buang
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Guang Sheng
authors.initials: GS
authors.lastname: Ling
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Greg
authors.initials: G
authors.lastname: Crawford
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: H Terence
authors.initials: HT
authors.lastname: Cook
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Diane
authors.initials: D
authors.lastname: Scott
authors.affiliation: Haemato-Oncology Department, King's College London, UK.
authors.forename: Francesco
authors.initials: F
authors.lastname: Dazzi
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK.
authors.forename: Jessica
authors.initials: J
authors.lastname: Strid
authors.affiliation: Centre for Complement and Inflammation Research, Department of Medicine, Imperial College London, London, UK. Electronic address: m.botto@imperial.ac.uk.
authors.forename: Marina
authors.initials: M
authors.lastname: Botto
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000634:Aminoquinolines / Q000009:adverse effects*; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism*; D003872:Dermatitis / Q000209:etiology / Q000276:immunology / Q000378:metabolism; D006801:Humans; D000077271:Imiquimod; D007111:Immunity, Cellular; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; C038245:C3 protein, human; D003176:Complement C3; D000077271:Imiquimod